4//SEC Filing
BRADLEY PHARMACEUTICALS INC 4
Accession 0000864268-04-000003
CIK 0000864268operating
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 3:08 PM ET
Size
8.8 KB
Accession
0000864268-04-000003
Insider Transaction Report
Form 4
LENCZYCKI R BRENT
VP - CFO
Transactions
- Discretionary Transaction
Common Stock
2003-12-12$24.25/sh+52$1,261→ 2,170 total(indirect: By 401(k))
Holdings
- 3,152
Stock Options (Right to buy)
Exercise: $8.81From: 2003-07-09Exp: 2004-07-08→ Common Stock (3,152 underlying) - 1,265
Stock Options (Right to buy)
Exercise: $10.58From: 2003-07-09Exp: 2006-07-08→ Common Stock (1,265 underlying) - 8,606
Common Stock
- 2,864(indirect: By 401(k))
Common Stock
- 15,000
Stock Options (Right to buy)
Exercise: $2.00From: 2004-03-30Exp: 2011-03-29→ Common Stock (15,000 underlying) - 6,000
Stock Options (Right to buy)
Exercise: $2.19From: 2001-03-13Exp: 2008-03-12→ Common Stock (6,000 underlying) - 60,000
Stock Options (Right to buy)
Exercise: $7.05From: 2004-07-09Exp: 2011-07-08→ Common Stock (60,000 underlying)
Documents
Issuer
BRADLEY PHARMACEUTICALS INC
CIK 0000864268
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000864268
Filing Metadata
- Form type
- 4
- Filed
- Jan 8, 7:00 PM ET
- Accepted
- Jan 9, 3:08 PM ET
- Size
- 8.8 KB